The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection-Reference-Cited by-同舟云学术

The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection

Published:2015-05-05 Issue:9 Volume:162 Page:619-629
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Linas Benjamin P.¹,Barter Devra M.¹,Morgan Jake R.¹,Pho Mai T.¹,Leff Jared A.¹,Schackman Bruce R.¹,Horsburgh C. Robert¹,Assoumou Sabrina A.¹,Salomon Joshua A.¹,Weinstein Milton C.¹,Freedberg Kenneth A.¹,Kim Arthur Y.¹

Affiliation:

1. From Boston Medical Center, Boston University School of Public Health, Harvard School of Public Health, and Massachusetts General Hospital, Boston, Massachusetts; University of Chicago, Chicago, Illinois; and Weill Cornell Medical College, New York, New York.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The limits of innovation: Directly addressing known challenges is necessary to improve the real‐world experience of novel medications for opioid use disorder;Academic Emergency Medicine;2023-10-28

2. Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder;JAMA Network Open;2023-09-13

3. A Microsimulation Study of the Cost-Effectiveness of Hepatitis C Virus Screening Frequencies in Hemodialysis Centers;Journal of the American Society of Nephrology;2023-02

4. M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID;Trials;2022-04-23

5. Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System;Value in Health;2022-02